• 1
    Oliveria SA, Chen RS, McCarthy BD, et al. Hypertension knowledge, awareness, and attitudes in a hypertensive population. J Gen Intern Med. 2005;20:219225.
  • 2
    Miller NH, Berra K, Long J. Hypertension 2008–awareness, understanding, and treatment of previously diagnosed hypertension in baby boomers and seniors: a survey conducted by Harris Interactive on behalf of the Preventive Cardiovascular Nurses Association. J Clin Hypertens. (Greenwich) 2010;12:328334.
  • 3
    Egan BM, Lackland DT, Cutler NE. Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med. 2003;163:681687.
  • 4
    Wiklund I, Halling K, Rydén-Bergsten T, Fletcher A. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study. Blood Press. 1997;6:357364.
  • 5
    Weir MR, Prisant LM, Papademetriou V, et al. Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy. Am J Hypertens. 1996;9:854859.
  • 6
    Bulpitt CJ. The effect of lowering blood pressure on quality of life. Curr Hypertens Rep. 2000;2:509.
  • 7
    Schmieder RE, Grassi G, Kjeldsen SE. Patients with treatment-resistant hypertension report increased stress and anxiety: a worldwide study. J Hypertens. 2013;31:610615.
  • 8
    Dupuy HJ. The psychological general well being. In: Wenger NK, Mattson ME, Furburg CD, et al, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, NY. LeJacq Publishing Inc; 1984:170183.
  • 9
    Weber MA, Bakris GL, Neutel JM, et al. Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker. J Clin Hypertens (Greenwich). 2003;5:322329.
  • 10
    Calhoun DA, Jones D, Textor S, et al; American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510e526.
  • 11
    Chobanian AV, Bakris GL, Black HR, et al; Joint National Committee on Prevention; Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:12061252.
  • 12
    Pierdomenico SD, Lapenna D, Bucci A, et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens. 2005;18:14221428.
  • 13
    Weber MA, Julius S, Kjeldsen SE, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet. 2004;19:363.
  • 14
    Sleight P, Redon J, Verdecchia P, et al; ONTARGET investigators. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens. 2009;27:13601369.
  • 15
    Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304:6168.
  • 16
    Weber MA, Bakris GL, Hester A, et al. Systolic blood pressure and cardiovascular outcomes during treatment of hypertension. Am J Med. 2013;126:501508.
  • 17
    Weber MA, Julius S, Kjeldsen SE, et al. Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy. J Hypertens. 2012;30:22132222.
  • 18
    de la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57:898902.
  • 19
    Jung O, Gechter JL, Wunder C, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31:766774.